Ortho Evra’s First Hurdle Is Advisory Panel; Second Is Withdrawal Petition
This article was originally published in The Pink Sheet Daily
Executive Summary
As Public Citizen presses to get J&J’s transdermal birth control pulled from the market, data suggest a higher risk of blood clots with the patch than with combination oral contraceptives, FDA says, but none of the studies provide a definitive answer on the drug’s relative safety.